Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Bonavida, Benjamin; Chouaib, Salem

Springer International Publishing AG

10/2016

353

Mole

Inglês

9783319380674

15 a 20 dias

6363

Descrição não disponível.
1 Resistance of Cancer Stem Cells to Cell-mediated Immune Responses .-2 Role of Co-inhibitory Molecules in Tumor Escape from CTL attack.-3 Role of the Non-classical HLA Class I Antigens for Immune Escape .-4 Integrins: Friends or Foes of Antitumor Cytotoxic T Lymphocyte Response.-5 Cytotoxic T Lymphocytes and Their Granzymes: An Overview.-6 Hypoxia: A Formidable Saboteur of the Anti-tumor Response.-7 Mechanisms and Modulation of Tumor Microenvironment-Induced Immune Resistance .-8 Evasion of Cytotoxic Lymphocyte and Pulmonary Macrophage Mediated Immune Responses in Lung Cancer.-9 Sensitization of Immune-Resistant Tumor Cells to CTL-mediated Apoptosis via Interference at the Dysregulated NF-?B/Snail/YY1/PI3K/RKIP/PTEN Resistant Loop.-10 Overcoming Cancer Cell Resistance to Death Receptor Targeted Therapies.-11 Pancreatic Cancer Resistance to TRAIL Therapy: Regulators of the Death Inducing Signaling Complex.-12 Resistance of Carcinoma Cells to CTL-mediated Immunotherapy.-13 Cancer Induced Immunosuppression and its Modulation by Signal Inhibitors.-14 Quality of CTL Therapies: A Changing Landscape.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
HDAC inhibitors;Proteasome inhibitors;apoptosis;cytotoxic t lymphocytes;drug-resistant cancer cells;epitopes;antibacterial drug resistance